Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Falconi

Showing results (261-270 of 639) with videos related to

Pageof 64
Sort By:
Pancreas|June 17, 2020
The Applicability of a Checklist for the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency: Results of the Italian Exocrine Pancreatic Insufficiency RegistryRaffaele Pezzilli, Gabriele Capurso, Massimo Falconi, et al.
The British Journal of Surgery|August 30, 2024
Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II studyStefano Partelli, Luca Landoni, Mirco Bartolomei, et al.
Annals of Surgical Oncology|September 11, 2016
Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver MetastasesEmilio Bertani, Nicola Fazio, Davide Radice, et al.
Annals of Surgical Oncology|July 14, 2021
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence SurvivalGiulio Belfiori, Stefano Crippa, Aleotti Francesca, et al.
Surgery|July 28, 2021
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomyGiampaolo Perri, Giovanni Marchegiani, Stefano Partelli, et al.
Surgery|March 17, 2023
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancerAlessandro Cucchetti, Benjamin Djulbegovic, Stefano Crippa, et al.
Expert Review of Gastroenterology & Hepatology|April 22, 2024
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasmsAnna Battistella, Matteo Tacelli, Paola Mapelli, et al.
European Journal of Internal Medicine|January 6, 2020
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related diseaseCorrado Campochiaro, Emanuel Della-Torre, Marco Lanzillotta, et al.
Surgical Endoscopy|January 19, 2020
Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weightingStefano Partelli, Valentina Andreasi, Paola Maria Vittoria Rancoita, et al.
Critical Reviews in Oncology/Hematology|December 9, 2015
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy--A literature reviewRossana Berardi, Silvia Rinaldi, Mariangela Torniai, et al.
Pageof 64

Showing results (261-270 of 639) with videos related to

Sort By:
Pageof 64
Pancreas|June 17, 2020
The Applicability of a Checklist for the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency: Results of the Italian Exocrine Pancreatic Insufficiency RegistryRaffaele Pezzilli, Gabriele Capurso, Massimo Falconi, et al.
The British Journal of Surgery|August 30, 2024
Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II studyStefano Partelli, Luca Landoni, Mirco Bartolomei, et al.
Annals of Surgical Oncology|September 11, 2016
Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver MetastasesEmilio Bertani, Nicola Fazio, Davide Radice, et al.
Annals of Surgical Oncology|July 14, 2021
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence SurvivalGiulio Belfiori, Stefano Crippa, Aleotti Francesca, et al.
Surgery|July 28, 2021
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomyGiampaolo Perri, Giovanni Marchegiani, Stefano Partelli, et al.
Surgery|March 17, 2023
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancerAlessandro Cucchetti, Benjamin Djulbegovic, Stefano Crippa, et al.
Expert Review of Gastroenterology & Hepatology|April 22, 2024
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasmsAnna Battistella, Matteo Tacelli, Paola Mapelli, et al.
European Journal of Internal Medicine|January 6, 2020
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related diseaseCorrado Campochiaro, Emanuel Della-Torre, Marco Lanzillotta, et al.
Surgical Endoscopy|January 19, 2020
Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weightingStefano Partelli, Valentina Andreasi, Paola Maria Vittoria Rancoita, et al.
Critical Reviews in Oncology/Hematology|December 9, 2015
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy--A literature reviewRossana Berardi, Silvia Rinaldi, Mariangela Torniai, et al.
Pageof 64